Royal Bank of Canada’s Redhill Biopharma RDHL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $0 | Buy |
351
+350
| +35,000% | +$323 | ﹤0.01% | 7729 |
|
|
2026
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 7591 |
|
|
2025
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 7549 |
|
|
2025
Q3 | $0 | Sell |
1
-3
| -75% | -$5 | ﹤0.01% | 7451 |
|
|
2025
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 7288 |
|
|
2025
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 7171 |
|
|
2024
Q4 | $0 | Buy |
4
+1
| +33% | +$8 | ﹤0.01% | 7187 |
|
|
2024
Q3 | $0 | Sell |
3
-14
| -82% | -$138 | ﹤0.01% | 7327 |
|
|
2024
Q2 | $0 | Buy |
17
+9
| +113% | +$100 | ﹤0.01% | 7448 |
|
|
2024
Q1 | $0 | Buy |
8
+2
| +33% | +$36 | ﹤0.01% | 7487 |
|
|
2023
Q4 | $0 | Sell |
6
-84
| -93% | -$1.71K | ﹤0.01% | 7497 |
|
|
2023
Q3 | $1K | Buy |
90
+84
| +1,400% | +$2.2K | ﹤0.01% | 6930 |
|
|
2023
Q2 | $0 | Buy |
6
+1
| +20% | +$58 | ﹤0.01% | 7586 |
|
|
2023
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 7404 |
|
|
2022
Q4 | $1K | Buy |
5
+1
| +25% | +$433 | ﹤0.01% | 7071 |
|
|
2022
Q3 | $3K | Buy |
4
+3
| +300% | +$2.61K | ﹤0.01% | 6915 |
|
|
2022
Q2 | $1K | Sell |
1
-1
| -50% | -$1.37K | ﹤0.01% | 7186 |
|
|
2022
Q1 | $4K | Sell |
2
-1
| -33% | -$2.37K | ﹤0.01% | 7333 |
|
|
2021
Q4 | $8K | Sell |
3
-2
| -40% | -$8K | ﹤0.01% | 7119 |
|
|
2021
Q3 | $25K | Hold |
5
| – | – | ﹤0.01% | 6581 |
|
|
2021
Q2 | $38K | Hold |
5
| – | – | ﹤0.01% | 6216 |
|
|
2021
Q1 | $36K | Sell |
5
-1
| -17% | -$8.39K | ﹤0.01% | 6094 |
|
|
2020
Q4 | $46K | Sell |
6
-1
| -14% | -$8.99K | ﹤0.01% | 5691 |
|
|
2020
Q3 | $68K | Buy |
7
+2
| +40% | +$16.4K | ﹤0.01% | 5201 |
|
|
2020
Q2 | $36K | Buy |
5
+1
| +25% | +$6.89K | ﹤0.01% | 5364 |
|
|
2020
Q1 | $19K | Buy |
4
+1
| +33% | +$5K | ﹤0.01% | 5575 |
|
|
2019
Q4 | $18K | Hold |
3
| – | – | ﹤0.01% | 5905 |
|
|
2019
Q3 | $21K | Hold |
3
| – | – | ﹤0.01% | 5488 |
|
|
2019
Q2 | $19K | Hold |
3
| – | – | ﹤0.01% | 5746 |
|
|
2019
Q1 | $25K | Hold |
3
| – | – | ﹤0.01% | 5550 |
|
|
2018
Q4 | $16K | Hold |
3
| – | – | ﹤0.01% | 5683 |
|
|
2018
Q3 | $26K | Buy |
+3
| New | +$24.4K | ﹤0.01% | 5550 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 6106 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 6121 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 6291 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 6469 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 6202 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 6291 |
|
|
2016
Q3 | – | Sell |
-21
| Closed | -$228K | – | 6549 |
|
|
2016
Q2 | $228K | Hold |
21
| – | – | ﹤0.01% | 4325 |
|
|
2016
Q1 | $259K | Hold |
21
| – | – | ﹤0.01% | 4185 |
|
|
2015
Q4 | $270K | Hold |
21
| – | – | ﹤0.01% | 4315 |
|
|
2015
Q3 | $271K | Hold |
21
| – | – | ﹤0.01% | 4066 |
|
|
2015
Q2 | $369K | Buy |
+21
| New | +$333K | ﹤0.01% | 3893 |
|
Other funds holding RDHL
YAG
GS
GI
FDCDDQ
SS
Royal Bank of Canada's RDHL Position: Q2 2026 in Review
Royal Bank of Canada increased its Redhill Biopharma (RDHL) stake by 35,000% in Q2 2026, buying an estimated $323 and bringing the position to 351 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7729.
Royal Bank of Canada first reported a position in RDHL in Q2 2015 and has held it in 37 quarters since. The position peaked at $369K in Q2 2015. 14 funds tracked by Wall St. Rank hold RDHL as of Q2 2026.
- Royal Bank of Canada held 351 shares of Redhill Biopharma worth $0 as of Q2 2026.
- Royal Bank of Canada bought 350 Redhill Biopharma shares in Q2 2026, an estimated $323.
- Redhill Biopharma made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #7729 holding.
- Royal Bank of Canada first reported a position in Redhill Biopharma in Q2 2015 and has held it in 37 quarters since.
- Royal Bank of Canada's Redhill Biopharma position peaked at $369K in Q2 2015.
- 14 funds tracked by Wall St. Rank held Redhill Biopharma as of Q2 2026.
Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.